These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24568648)

  • 1. Association between the FAS rs2234767G/A polymorphism and cancer risk: a systematic review and meta-analysis.
    Wang X; Xing GH; Fan CC
    DNA Cell Biol; 2014 May; 33(5):320-7. PubMed ID: 24568648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAS-1377 G/A (rs2234767) polymorphism and cancer susceptibility: a meta-analysis of 17,858 cases and 24,311 controls.
    Zhong-Xing Z; Yuan-Yuan M; Hai Zhen M; Jian-Gang Z; Li-Feng Z
    PLoS One; 2013; 8(8):e73700. PubMed ID: 24014103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
    Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
    Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between FAS gene -670 A/G and -1377 G/A polymorphisms and the risk of autoimmune diseases: a meta-analysis.
    Yan H; Hong Y; Cai Y
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31840751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas -670A/G (rs1800682) polymorphism and digestive cancer risk in Asians: a meta-analysis.
    Yuan HP; Liu QD; Li GQ; Cong YQ
    Genet Test Mol Biomarkers; 2014 Jul; 18(7):482-8. PubMed ID: 24800976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between Fas rs180082 polymorphism and risk of cervical cancer: an update by meta-analysis.
    Chen X; Mo W; Peng Q; Su X
    BMC Med Genet; 2013 Jul; 14():71. PubMed ID: 23865866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
    Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
    Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas and FasL promoter polymorphisms and susceptibility to HBV infection: A systematic review and meta-analysis.
    Mohammadi A; Salehi M; Khanbabaei H; Sheikhesmaeili F; Tajik N; Alavian SM
    Infect Genet Evol; 2019 Dec; 76():104003. PubMed ID: 31425784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between FAS 1377G>A polymorphism and breast cancer susceptibility: a meta-analysis.
    Li K; Li W; Zou H; Zhao L
    Tumour Biol; 2014 Jan; 35(1):351-6. PubMed ID: 23979975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Fas/FasL polymorphisms and susceptibility to cervical cancer: a meta-analysis.
    Wang GQ; Bao L; Zhao XX; Zhang J; Nan KJ
    Tumour Biol; 2014 May; 35(5):4107-12. PubMed ID: 24375196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Fas gene polymorphisms with systemic lupus erythematosus: a meta-analysis.
    Xiang N; Li XM; Wang GS; Tao JH; Li XP
    Mol Biol Rep; 2013 Jan; 40(1):407-15. PubMed ID: 23065220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between FAS single nucleotide polymorphisms and breast carcinoma susceptibility in Asia.
    Chen Y; Wang H; Yan Y; Ren M; Yan C; Wang B
    Medicine (Baltimore); 2019 Dec; 98(49):e18240. PubMed ID: 31804351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
    Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
    Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Fas/FasL gene polymorphism and musculoskeletal degenerative diseases: a meta-analysis.
    Huang D; Xiao J; Deng X; Ma K; Liang H; Shi D; Wu F; Shao Z
    BMC Musculoskelet Disord; 2018 May; 19(1):137. PubMed ID: 29734947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between FAS-1377 G/A polymorphism and susceptibility to gastric cancer: evidence from a meta-analysis.
    Wu Z; Wang H; Chu X; Chen J; Fang S
    Tumour Biol; 2013 Aug; 34(4):2147-52. PubMed ID: 23636796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of tumor necrosis factor-α and FAS/FASL polymorphisms with risk of pre-eclampsia.
    Lin Y; Wang L; Yan Y; Zhou W; Chen Z
    Hypertens Pregnancy; 2019 Feb; 38(1):20-31. PubMed ID: 30606056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAS-1377 A/G polymorphism in breast cancer: a meta-analysis.
    Zeng J; Fang Y; Li P
    Tumour Biol; 2014 Mar; 35(3):2575-81. PubMed ID: 24185967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Fas -1377 G/A polymorphism with susceptibility to cancer.
    Geng P; Li J; Ou J; Xie G; Wang N; Xiang L; Sa R; Liu C; Li H; Liang H
    PLoS One; 2014; 9(2):e88748. PubMed ID: 24558420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
    Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
    PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.